Cargando…

No effect of pirfenidone treatment in fulminant bleomycin-induced pneumonitis

Bleomycin-induced pneumonitis (BIP) is a serious and potentially fatal adverse effect of bleomycin. Currently, BIP is treated on an empirical basis with high dose steroid. Pirfenidone is a new antifibrotic drug, which has been proven beneficial in idiopathic pulmonary fibrosis and is able to inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bendstrup, Elisabeth, Hyldgaard, Charlotte, Agerbæk, Mads, Andersen, Charlotte U., Hilberg, Ole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061441/ https://www.ncbi.nlm.nih.gov/pubmed/26029540 http://dx.doi.org/10.1016/j.rmcr.2013.12.010

Ejemplares similares

Hypersensitivity pneumonitis among wind musicians – an overlooked disease?
por: Møller, Janne, et al.
Publicado: (2017)

Clinical characteristics and outcome in patients with antisynthetase syndrome associated interstitial lung disease: a retrospective cohort study
por: Jensen, Mads Lynge, et al.
Publicado: (2019)

Economic consequences of idiopathic pulmonary fibrosis in Denmark
por: Hilberg, Ole, et al.
Publicado: (2018)

Intravenous immunoglobulin treatment stabilizing a patient with Anti-PL7 antisynthetase syndrome with interstitial lung disease and eosinophilic inflammation
por: Peshbahar, Soran, et al.
Publicado: (2022)

Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries
por: Bendstrup, Elisabeth, et al.
Publicado: (2015)

Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma
por: Sakamoto, Koji, et al.
Publicado: (2017)

NT-proBNP <95 ng/l can exclude pulmonary hypertension on echocardiography at diagnostic workup in patients with interstitial lung disease
por: Andersen, Charlotte, et al.
Publicado: (2016)

Treatment of steroid‐resistant checkpoint inhibitor pneumonitis with pirfenidone: A case report
por: Miao, Kang, et al.
Publicado: (2021)

Incidence, prevalence and regional distribution of systemic sclerosis and related interstitial lung Disease: A nationwide retrospective cohort study
por: Knarborg, Malene, et al.
Publicado: (2022)

Comorbidity and mortality in systemic sclerosis and matched controls: Impact of interstitial lung disease. A population based cohort study based on health registry data
por: Knarborg, Malene, et al.
Publicado: (2023)

Increasing awareness of corticosteroid hypersensitivity reactions is important
por: Knarborg, Malene, et al.
Publicado: (2013)

Palliation of chronic breathlessness with morphine in patients with fibrotic interstitial lung disease – a randomised placebo-controlled trial
por: Kronborg-White, Sissel, et al.
Publicado: (2020)

Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma
por: Dei-Adomakoh, Yvonne A, et al.
Publicado: (2020)

Emphysema mimicking interstitial lung disease: Two case reports
por: Juhl, Kasper S., et al.
Publicado: (2014)

Protective efficacy of pirfenidone in rats with pulmonary fibrosis induced by bleomycin
por: Demirkol, Barış, et al.
Publicado: (2023)

Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality
por: Hyldgaard, Charlotte, et al.
Publicado: (2020)

Fulminant lupus pneumonitis complicating systemic lupus erythematosus in the elderly
por: Helali, Wiem, et al.
Publicado: (2023)

Pirfenidone suppresses bleomycin-induced pulmonary fibrosis and periostin expression in rats
por: Song, Xiaoxia, et al.
Publicado: (2018)

Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
por: Salih, Goran Nadir, et al.
Publicado: (2016)

Chronic granulomatous disease presenting at age 52 with fulminant mulch pneumonitis
por: Marois, Louis, et al.
Publicado: (2022)

Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis
por: Inomata, Minoru, et al.
Publicado: (2014)

Pirfenidone-induced Eosinophilic Pleurisy
por: Hase, Isano, et al.
Publicado: (2017)

Pneumomediastinum, subcutaneous emphysema, and pneumothorax after a pulmonary function testing in a patient with bleomycin-induced interstitial pneumonitis
por: Araujo, Mariana Sponholz, et al.
Publicado: (2013)

Design and rationale of ProSar, the first Danish sarcoidosis registry
por: Møller, Janne, et al.
Publicado: (2021)

Immunoglobulin G4-related pleuritis – A case report
por: Gajewska, Marta E., et al.
Publicado: (2016)

Pirfenidone activates cannabinoid receptor 2 in a mouse model of bleomycin-induced pulmonary fibrosis
por: Liu, Jinhong, et al.
Publicado: (2019)

Interstitial Lung Disease in Connective Tissue Diseases: Survival Patterns in a Population-Based Cohort
por: Hyldgaard, Charlotte, et al.
Publicado: (2021)

Opioids: an unexplored option for treatment of dyspnea in IPF
por: Kohberg, Charlotte, et al.
Publicado: (2016)

Spontaneous Pneumomediastinum and Bilateral Pneumothoraces in a Patient with Bleomycin-Induced Pneumonitis
por: Barras, Matthieu, et al.
Publicado: (2017)

Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium
por: Liu, Yuan, et al.
Publicado: (2017)

Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians
por: Bendstrup, Elisabeth, et al.
Publicado: (2019)

Bleomycin-Induced Fulminant Hyperpyrexia: A Report of Two Cases and Review of Literature
por: Jhatial, Mussadique Ali, et al.
Publicado: (2022)

A Case of Pirfenidone-Induced Photosensitive Drug Eruption
por: Jeong, Soo Hyun, et al.
Publicado: (2023)

Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation
por: Maher, Toby M., et al.
Publicado: (2019)

Clusters of comorbidities in fibrotic hypersensitivity pneumonitis
por: Prior, Thomas Skovhus, et al.
Publicado: (2022)

Bleomycin-induced flagellate dermatitis
por: Mota, Guilherme Devidé, et al.
Publicado: (2014)

Bleomycin‐induced flagellate hyperpigmentation
por: Larson, Krista N., et al.
Publicado: (2017)

Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone
por: Reddy, Manoj, et al.
Publicado: (2016)

Pemetrexed induced pneumonitis
por: Dhakal, Binod, et al.
Publicado: (2011)

A case of fulminant perimyocarditis leading to extensive ECMO treatment and spinal injury resulting in paraplegia
por: Magnusson, Peter, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gpddbljlm34ckgvorbon689sqb